{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:45Z","timestamp":1792098465732,"version":"4.4.0"},"reference-count":29,"publisher":"European Respiratory Society (ERS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2009,10,28]]},"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p>We sought to determine the type of pulmonary involvement in microscopic polyangiitis (MPA), primarily focusing on pulmonary fibrosis (PF), its prevalence, temporal relationship with other disease manifestations and outcome.<\/jats:p>\n                  <jats:p>33 patients (16 males) with biopsy proven perinuclear anti-neutrophilic cytoplasmic antibody-positive MPA (age 63.5 yrs) participated in the study. Pulmonary involvement was assessed using standard methods, including radiographic imaging (chest radiographs and high-resolution computed tomography), pulmonary function testing, bronchoscopy and bronchoalveolar lavage, and, if indicated, lung biopsy. All-cause mortality was analysed by the Kaplan\u2013Meier method and was compared between MPA patients with and without PF.<\/jats:p>\n                  <jats:p>At the time of diagnosis, renal involvement was detected in all patients, with renal biopsies being consistent with segmental necrotising glomerulonephritis in all patients. The most common respiratory symptom was haemoptysis, which was found in nine (27%) patients. PF was present in 12 (36%) patients at the time of diagnosis, whereas one patient developed PF while on therapy \u223c10 yrs after disease diagnosis. In seven patients with PF, respiratory symptoms related to fibrosis preceded other disease manifestations by a median (range) period of 13 (5\u2013120) months. Patients were followed up for a period of 38\u00b130 months. Presence of PF was associated with increased mortality (p = 0.02), with six deaths occurring in the fibrotic group and one in the nonfibrotic group. In the fibrotic group most deaths were related to PF.<\/jats:p>\n                  <jats:p>PF occurs frequently in MPA, may precede other disease manifestations by a variable length of time and has a poor prognosis.<\/jats:p>","DOI":"10.1183\/09031936.00110109","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T21:58:05Z","timestamp":1258667885000},"page":"116-121","source":"Crossref","is-referenced-by-count":128,"title":["Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis"],"prefix":"10.1183","volume":"36","author":[{"given":"G.E.","family":"Tzelepis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kokosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Boki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zormpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2009,11,19]]},"reference":[{"key":"2024102020075242000_36.1.116.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11387"},{"key":"2024102020075242000_36.1.116.2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6"},{"key":"2024102020075242000_36.1.116.3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci015"},{"key":"2024102020075242000_36.1.116.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.rct.0000135280.79012.c7"},{"key":"2024102020075242000_36.1.116.5","doi-asserted-by":"publisher","DOI":"10.1080\/03009749950155643"},{"key":"2024102020075242000_36.1.116.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22633"},{"key":"2024102020075242000_36.1.116.7","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.3.220"},{"key":"2024102020075242000_36.1.116.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.1.297"},{"key":"2024102020075242000_36.1.116.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.04.023"},{"key":"2024102020075242000_36.1.116.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096131"},{"key":"2024102020075242000_36.1.116.11","first-page":"384","article-title":"Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis","volume":"53","author":"Hiromura","year":"2000","journal-title":"Clin Nephrol"},{"key":"2024102020075242000_36.1.116.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2004.00581.x"},{"key":"2024102020075242000_36.1.116.13","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200103000-00009"},{"key":"2024102020075242000_36.1.116.14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0025-6196(12)62575-0","article-title":"Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients","volume":"65","author":"Nada","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"2024102020075242000_36.1.116.15","first-page":"337","article-title":"Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution","volume":"55","author":"Souid","year":"2001","journal-title":"Clin Nephrol"},{"key":"2024102020075242000_36.1.116.16","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8065-7"},{"key":"2024102020075242000_36.1.116.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054593"},{"key":"2024102020075242000_36.1.116.18","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200007000-00003"},{"key":"2024102020075242000_36.1.116.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-3005"},{"key":"2024102020075242000_36.1.116.20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2024102020075242000_36.1.116.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806"},{"key":"2024102020075242000_36.1.116.22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.1.293"},{"key":"2024102020075242000_36.1.116.23","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14a20.x"},{"key":"2024102020075242000_36.1.116.24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcp\/104.1.7","article-title":"The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase","volume":"104","author":"Gaudin","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"2024102020075242000_36.1.116.25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","article-title":"Antimyeloperoxidase-associated lung disease. An experimental model","volume":"160","author":"Foucher","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020075242000_36.1.116.26","first-page":"235","article-title":"A lung biopsy is unnecessary in the management of ANCA-positive patients with chest-roentgenographic abnormalities","volume":"13","author":"Cordier","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102020075242000_36.1.116.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200412-1756OC"},{"key":"2024102020075242000_36.1.116.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00060107"},{"key":"2024102020075242000_36.1.116.29","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.ats3-00"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00110109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:30:22Z","timestamp":1740360622000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00110109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,6,30]]},"published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1183\/09031936.00110109"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00110109","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3032959.2710057","asserted-by":"object"}]},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,19]]}}}